Oxaliplatin-induced lung fibrosis
Abstract: Oxaliplatin has been approved for use as an adjuvant treatment in stage III colorectal carcinoma by the US-FDA. The majority of toxicity caused by this drug is manageable. However, rare, isolated cases of pulmonary fibrosis induced by this drug have been reported in literature. We report one such case of rapidly evolving pulmonary fibrosis following treatment with oxaliplatin.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Oxaliplatin-induced lung fibrosis ; volume:30 ; number:03 ; year:2009 ; pages:116-118
Indian journal of medical & paediatric oncology ; 30, Heft 03 (2009), 116-118
- Contributor
-
Shah, Arpan
Udwadia, Zarir F.
Almel, Sachin
- DOI
-
10.4103/0971-5851.64259
- URN
-
urn:nbn:de:101:1-2022031217034905792839
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shah, Arpan
- Udwadia, Zarir F.
- Almel, Sachin
Other Objects (12)
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Myofibroblasts and lung fibrosis induced by carbon nanotube exposure
An Agent-Based Model of Radiation-Induced Lung Fibrosis
Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia
Oxaliplatin-induced thrombotic microangiopathy: a case report
Identification of molecular signatures involved in radiation-induced lung fibrosis
Pharmacological targeting of BET proteins attenuates radiation-induced lung fibrosis
Neuronal changes in oxaliplatin-induced acute peripheral pain
ISM1 suppresses LPS-induced acute lung injury and post-injury lung fibrosis in mice
Induced pluripotent stem cell-derived lung alveolar epithelial type II cells reduce damage in bleomycin-induced lung fibrosis
Macrophage autophagy protects mice from cerium oxide nanoparticle-induced lung fibrosis
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Myofibroblasts and lung fibrosis induced by carbon nanotube exposure
An Agent-Based Model of Radiation-Induced Lung Fibrosis
Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia
Oxaliplatin-induced thrombotic microangiopathy: a case report
Identification of molecular signatures involved in radiation-induced lung fibrosis
Pharmacological targeting of BET proteins attenuates radiation-induced lung fibrosis
Neuronal changes in oxaliplatin-induced acute peripheral pain
ISM1 suppresses LPS-induced acute lung injury and post-injury lung fibrosis in mice
Induced pluripotent stem cell-derived lung alveolar epithelial type II cells reduce damage in bleomycin-induced lung fibrosis
Macrophage autophagy protects mice from cerium oxide nanoparticle-induced lung fibrosis
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Myofibroblasts and lung fibrosis induced by carbon nanotube exposure
An Agent-Based Model of Radiation-Induced Lung Fibrosis
Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia
Oxaliplatin-induced thrombotic microangiopathy: a case report
Identification of molecular signatures involved in radiation-induced lung fibrosis
Pharmacological targeting of BET proteins attenuates radiation-induced lung fibrosis
Neuronal changes in oxaliplatin-induced acute peripheral pain
ISM1 suppresses LPS-induced acute lung injury and post-injury lung fibrosis in mice
Induced pluripotent stem cell-derived lung alveolar epithelial type II cells reduce damage in bleomycin-induced lung fibrosis